Revolutionary approach links protein analysis and single-cell study to uncover disease mechanisms

A dif­fer­ent take on pro­tein degra­da­tion will en­ter hu­man tri­als as Ly­cia Ther­a­peu­tics, found­ed by No­bel lau­re­ate Car­olyn Bertozzi, has re­fu­eled with $106.6 mil­lion. The

In January this year, the US House Select Committee on the Strategic Competition between the US and the Chinese Communist Party introduced the Biosecure Act,

Fred Pelzman is an associate professor of medicine at Weill Cornell, and has been a practicing internist for nearly 30 years. He is medical director